Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Radiofrequency Resection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 7 of 0 results

Not applicableStudy completedNCT01890291
What this trial is testing

Long Term Follow-Up Study of Immuncell-LC Group and Non-Treatment Group in Hepatocellular Carcinoma Patients.

Who this might be right for
Hepatocellular Carcinoma
GC Cell Corporation 162
Not applicableStudy completedNCT05193253
What this trial is testing

Long-term Outcomes of Ablation, Liver Resection, and Liver Transplant as First-line Treatment for Solitary HCC of 3 cm or Less

Who this might be right for
Hepatocellular Carcinoma
University Health Network, Toronto 119
Not applicableStudy completedNCT01032044
What this trial is testing

CLE for Assessment of Neoplasia After Mucosal Ablation or Resection of Gastrointestinal Neoplasia

Who this might be right for
Barrett SyndromeBarrett's SyndromeBarrett's Esophagus+2 more
Mauna Kea Technologies 164
Not applicableStudy completedNCT04413526
What this trial is testing

Radiofrequency-assisted Liver Resection in Intractable Liver Cancer

Who this might be right for
Liver Cancer
Hepatopancreatobiliary Surgery Institute of Gansu Province 199
Testing effectiveness (Phase 2)Ended earlyNCT01686880
What this trial is testing

Y90 Radioembolization Prior to Surgical Resection or Radiofrequency for Hepatocellular Carcinoma in Cirrhotic Liver

Who this might be right for
Hepatocellular CarcinomaLiver Cirrhosis
Jules Bordet Institute 10
Not applicableStudy completedNCT01387503
What this trial is testing

Expansion of Conventional Criteria for Liver Transplantation in Hepatocellular Carcinoma Through Downstaging

Who this might be right for
Carcinoma, HepatocellularCirrhosis
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 74
Testing effectiveness (Phase 2)UnknownNCT03067493
What this trial is testing

RFA or Surgical Resection Combined With Neo-MASCT for Primary HCC: a Phase II Trial

Who this might be right for
Primary Liver CancerRadiofrequency AblationImmunotherapy+1 more
Sun Yat-sen University 98